Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	15 September 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,208,717	1.71%	466,648	0.36%
(2)	Derivatives (other than options):
		587,000	0.46%	388,524	0.30%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:
		2,795,717	2.17%	855,172	0.66%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	4	206.3400 USD
Purchase	30	207.4600 USD
Purchase	100	206.4400 USD
Purchase	100	205.9600 USD
Purchase	146	206.5224 USD
Purchase	152	207.6798 USD
Purchase	170	207.4905 USD
Purchase	200	207.7012 USD
Purchase	208	207.5521 USD
Purchase	297	207.6137 USD
Purchase	300	206.9416 USD
Purchase	300	207.9400 USD
Purchase	400	207.3050 USD
Purchase	420	207.8602 USD
Purchase	425	207.4477 USD
Purchase	970	207.7312 USD
Purchase	1,497	206.2984 USD
Purchase	2,190	207.2173 USD
Purchase	2,400	207.8293 USD
Purchase	3,701	206.2500 USD
Purchase	4,003	207.1525 USD
Purchase	7,759	206.7429 USD
Purchase	8,827	207.2995 USD
Purchase	10,339	206.9060 USD
Purchase	99,800	207.1234 USD
Sale	1	207.9900 USD
Sale	2	208.0150 USD
Sale	2	207.8550 USD
Sale	4	206.3400 USD
Sale	4	207.9512 USD
Sale	5	207.5900 USD
Sale	5	207.8320 USD
Sale	9	207.8444 USD
Sale	10	207.4440 USD
Sale	11	206.6500 USD
Sale	17	207.4750 USD
Sale	21	207.7573 USD
Sale	29	207.4700 USD
Sale	76	207.6798 USD
Sale	100	207.9500 USD
Sale	100	206.9700 USD
Sale	200	207.2350 USD
Sale	285	206.7756 USD
Sale	300	208.0441 USD
Sale	303	207.0021 USD
Sale	350	206.3671 USD
Sale	500	207.7810 USD
Sale	516	206.3383 USD
Sale	927	207.3341 USD
Sale	1,400	206.8357 USD
Sale	1,497	206.2984 USD
Sale	1,900	207.2255 USD
Sale	1,900	207.8421 USD
Sale	2,187	206.1725 USD
Sale	3,779	206.2500 USD
Sale	3,900	207.1641 USD
Sale	4,212	206.6353 USD
Sale	4,235	207.0072 USD
Sale	4,277	206.9685 USD
Sale	5,142	207.5274 USD
Sale	5,200	207.0489 USD
Sale	7,738	207.2026 USD
Sale	7,876	207.3083 USD
Sale	7,954	207.1910 USD
Sale	8,286	207.5730 USD
Sale	9,039	206.8860 USD
Sale	10,569	206.8754 USD
Sale	44,842	207.0666 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	16 Sep 2020
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection